Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly

•We provided an expanded evidenced-based review of all available pharmacotherapies and non-pharmacotherapies in the treatment of insomnia in the elderly. We also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the E...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of geriatric psychiatry 2021-06, Vol.29 (6), p.585-603
Hauptverfasser: Flaxer, Joseph M., Heyer, Arianna, Francois, Dimitry
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 603
container_issue 6
container_start_page 585
container_title The American journal of geriatric psychiatry
container_volume 29
creator Flaxer, Joseph M.
Heyer, Arianna
Francois, Dimitry
description •We provided an expanded evidenced-based review of all available pharmacotherapies and non-pharmacotherapies in the treatment of insomnia in the elderly. We also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly.•We found no studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results We found four studies, two on relaxation training, one on sleep restriction, and one on stimulus control limited to the elderly with positive results.•The challenge of determining which non-pharmacological and pharmacological treatment truly improve insomnia sleep to a clinically relevant degree remains paramount in the field of insomnia research. Further investigation with comprehensive meta-analyses and systematic reviews would add rigor to our understanding of the effectiveness of these options. Insomnia in the elderly is a prevalent condition that poses treatment challenges to practitioners across medical fields. There are many behavioral and other nonpharmacological therapies, 18 Food and Drug Administration-approved pharmacotherapies, and numerous off-label, over the counter and alternative treatments. Most reviews on this subject focus either on pharmacological treatments or behavioral treatments. The authors provide a combined review of available pharmacological and nonpharmacological treatments. The authors narratively reviewed each treatment from our literature search, tabled results with the highest level of available evidence on 5 major sleep outcomes and evaluated these results for clinical significance. The authors also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly. The authors found the most rigorous evidence supporting Cognitive Behavioral Therapy for Insomnia as a first-line treatment option, with longer lasting therapeutic effects than treatment with pharmacologic agents alone. The authors also found evidence of similar outcomes from other behavioral interventions, such as Brief Behavioral Therapy for Insomnia and relaxation training. The authors found 4 studies, 2 on relaxation training, 1 on sleep restriction, and 1 on stimulus control limited to the elderly with clinically significant results. The authors found no pharmacological studies limited to the elderly on treatments not contraindicated by Beers crite
doi_str_mv 10.1016/j.jagp.2020.10.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2463106023</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1064748120305315</els_id><sourcerecordid>2463106023</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-597999b8fa758ddd7d765636f2bcdc158f3336448cd2b83fe471f21bc9d958963</originalsourceid><addsrcrecordid>eNp9kctu1DAUhiMEoqXwAiyQJTbdZPAtTozY0NEUKlWAoKwtx5epI8ce7GRQn6EvjdMpXXTRlY-Ovv-Xdb6qeovgCkHEPgyrQW53KwzxslhBhJ5Vx6ihTd1iRJ-XGTJat7RDR9WrnAcIIeOMvqyOCMGo46g5rm43e6dNUEbXZzIbDX6avTN_gQwabPbSz3JyMYBowdq74JT04JfbBmfLWFIfwbcYdtcyjVJFH7d3wJL98Wh3lYycRhOmpeoi5DgGJ4ELYLo2YOO1Sf7mdfXCSp_Nm_v3pPp9vrlaf60vv3-5WH--rBXp6FQ3vOWc952VbdNprVvdsoYRZnGvtEJNZwkhjNJOadx3xBraIotRr7jmTccZOalOD727FP_MJk9idFkZ72Uwcc4CU0bK6SAmBX3_CB3inEL5ncANxS3hqIWFwgdKpZhzMlbskhtluhEIikWVGMSiSiyqll1RVULv7qvnfjT6IfLfTQE-HQBTblGkJJGVu1PlklGT0NE91f8PmnOlig</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2542739170</pqid></control><display><type>article</type><title>Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly</title><source>Alma/SFX Local Collection</source><creator>Flaxer, Joseph M. ; Heyer, Arianna ; Francois, Dimitry</creator><creatorcontrib>Flaxer, Joseph M. ; Heyer, Arianna ; Francois, Dimitry</creatorcontrib><description>•We provided an expanded evidenced-based review of all available pharmacotherapies and non-pharmacotherapies in the treatment of insomnia in the elderly. We also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly.•We found no studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results We found four studies, two on relaxation training, one on sleep restriction, and one on stimulus control limited to the elderly with positive results.•The challenge of determining which non-pharmacological and pharmacological treatment truly improve insomnia sleep to a clinically relevant degree remains paramount in the field of insomnia research. Further investigation with comprehensive meta-analyses and systematic reviews would add rigor to our understanding of the effectiveness of these options. Insomnia in the elderly is a prevalent condition that poses treatment challenges to practitioners across medical fields. There are many behavioral and other nonpharmacological therapies, 18 Food and Drug Administration-approved pharmacotherapies, and numerous off-label, over the counter and alternative treatments. Most reviews on this subject focus either on pharmacological treatments or behavioral treatments. The authors provide a combined review of available pharmacological and nonpharmacological treatments. The authors narratively reviewed each treatment from our literature search, tabled results with the highest level of available evidence on 5 major sleep outcomes and evaluated these results for clinical significance. The authors also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly. The authors found the most rigorous evidence supporting Cognitive Behavioral Therapy for Insomnia as a first-line treatment option, with longer lasting therapeutic effects than treatment with pharmacologic agents alone. The authors also found evidence of similar outcomes from other behavioral interventions, such as Brief Behavioral Therapy for Insomnia and relaxation training. The authors found 4 studies, 2 on relaxation training, 1 on sleep restriction, and 1 on stimulus control limited to the elderly with clinically significant results. The authors found no pharmacological studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results. The authors discussed the challenges of determining clinical significance in sleep studies, the lack of studies restricted to the elderly, and the role of placebo effect.</description><identifier>ISSN: 1064-7481</identifier><identifier>EISSN: 1545-7214</identifier><identifier>DOI: 10.1016/j.jagp.2020.10.011</identifier><identifier>PMID: 33218915</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>CBT-I ; Clinical significance ; Cognitive behavioral therapy ; Drug therapy ; elderly ; Evidence-based medicine ; Insomnia ; nonpharmacological ; Older people ; pharmacological treatment ; Pharmacology ; Placebo effect</subject><ispartof>The American journal of geriatric psychiatry, 2021-06, Vol.29 (6), p.585-603</ispartof><rights>2020</rights><rights>Copyright © 2020. Published by Elsevier Inc.</rights><rights>Copyright Elsevier Limited Jun 2021</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-597999b8fa758ddd7d765636f2bcdc158f3336448cd2b83fe471f21bc9d958963</citedby><cites>FETCH-LOGICAL-c384t-597999b8fa758ddd7d765636f2bcdc158f3336448cd2b83fe471f21bc9d958963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33218915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Flaxer, Joseph M.</creatorcontrib><creatorcontrib>Heyer, Arianna</creatorcontrib><creatorcontrib>Francois, Dimitry</creatorcontrib><title>Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly</title><title>The American journal of geriatric psychiatry</title><addtitle>Am J Geriatr Psychiatry</addtitle><description>•We provided an expanded evidenced-based review of all available pharmacotherapies and non-pharmacotherapies in the treatment of insomnia in the elderly. We also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly.•We found no studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results We found four studies, two on relaxation training, one on sleep restriction, and one on stimulus control limited to the elderly with positive results.•The challenge of determining which non-pharmacological and pharmacological treatment truly improve insomnia sleep to a clinically relevant degree remains paramount in the field of insomnia research. Further investigation with comprehensive meta-analyses and systematic reviews would add rigor to our understanding of the effectiveness of these options. Insomnia in the elderly is a prevalent condition that poses treatment challenges to practitioners across medical fields. There are many behavioral and other nonpharmacological therapies, 18 Food and Drug Administration-approved pharmacotherapies, and numerous off-label, over the counter and alternative treatments. Most reviews on this subject focus either on pharmacological treatments or behavioral treatments. The authors provide a combined review of available pharmacological and nonpharmacological treatments. The authors narratively reviewed each treatment from our literature search, tabled results with the highest level of available evidence on 5 major sleep outcomes and evaluated these results for clinical significance. The authors also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly. The authors found the most rigorous evidence supporting Cognitive Behavioral Therapy for Insomnia as a first-line treatment option, with longer lasting therapeutic effects than treatment with pharmacologic agents alone. The authors also found evidence of similar outcomes from other behavioral interventions, such as Brief Behavioral Therapy for Insomnia and relaxation training. The authors found 4 studies, 2 on relaxation training, 1 on sleep restriction, and 1 on stimulus control limited to the elderly with clinically significant results. The authors found no pharmacological studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results. The authors discussed the challenges of determining clinical significance in sleep studies, the lack of studies restricted to the elderly, and the role of placebo effect.</description><subject>CBT-I</subject><subject>Clinical significance</subject><subject>Cognitive behavioral therapy</subject><subject>Drug therapy</subject><subject>elderly</subject><subject>Evidence-based medicine</subject><subject>Insomnia</subject><subject>nonpharmacological</subject><subject>Older people</subject><subject>pharmacological treatment</subject><subject>Pharmacology</subject><subject>Placebo effect</subject><issn>1064-7481</issn><issn>1545-7214</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kctu1DAUhiMEoqXwAiyQJTbdZPAtTozY0NEUKlWAoKwtx5epI8ce7GRQn6EvjdMpXXTRlY-Ovv-Xdb6qeovgCkHEPgyrQW53KwzxslhBhJ5Vx6ihTd1iRJ-XGTJat7RDR9WrnAcIIeOMvqyOCMGo46g5rm43e6dNUEbXZzIbDX6avTN_gQwabPbSz3JyMYBowdq74JT04JfbBmfLWFIfwbcYdtcyjVJFH7d3wJL98Wh3lYycRhOmpeoi5DgGJ4ELYLo2YOO1Sf7mdfXCSp_Nm_v3pPp9vrlaf60vv3-5WH--rBXp6FQ3vOWc952VbdNprVvdsoYRZnGvtEJNZwkhjNJOadx3xBraIotRr7jmTccZOalOD727FP_MJk9idFkZ72Uwcc4CU0bK6SAmBX3_CB3inEL5ncANxS3hqIWFwgdKpZhzMlbskhtluhEIikWVGMSiSiyqll1RVULv7qvnfjT6IfLfTQE-HQBTblGkJJGVu1PlklGT0NE91f8PmnOlig</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Flaxer, Joseph M.</creator><creator>Heyer, Arianna</creator><creator>Francois, Dimitry</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>4T-</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>202106</creationdate><title>Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly</title><author>Flaxer, Joseph M. ; Heyer, Arianna ; Francois, Dimitry</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-597999b8fa758ddd7d765636f2bcdc158f3336448cd2b83fe471f21bc9d958963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CBT-I</topic><topic>Clinical significance</topic><topic>Cognitive behavioral therapy</topic><topic>Drug therapy</topic><topic>elderly</topic><topic>Evidence-based medicine</topic><topic>Insomnia</topic><topic>nonpharmacological</topic><topic>Older people</topic><topic>pharmacological treatment</topic><topic>Pharmacology</topic><topic>Placebo effect</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Flaxer, Joseph M.</creatorcontrib><creatorcontrib>Heyer, Arianna</creatorcontrib><creatorcontrib>Francois, Dimitry</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Docstoc</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of geriatric psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Flaxer, Joseph M.</au><au>Heyer, Arianna</au><au>Francois, Dimitry</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly</atitle><jtitle>The American journal of geriatric psychiatry</jtitle><addtitle>Am J Geriatr Psychiatry</addtitle><date>2021-06</date><risdate>2021</risdate><volume>29</volume><issue>6</issue><spage>585</spage><epage>603</epage><pages>585-603</pages><issn>1064-7481</issn><eissn>1545-7214</eissn><abstract>•We provided an expanded evidenced-based review of all available pharmacotherapies and non-pharmacotherapies in the treatment of insomnia in the elderly. We also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly.•We found no studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results We found four studies, two on relaxation training, one on sleep restriction, and one on stimulus control limited to the elderly with positive results.•The challenge of determining which non-pharmacological and pharmacological treatment truly improve insomnia sleep to a clinically relevant degree remains paramount in the field of insomnia research. Further investigation with comprehensive meta-analyses and systematic reviews would add rigor to our understanding of the effectiveness of these options. Insomnia in the elderly is a prevalent condition that poses treatment challenges to practitioners across medical fields. There are many behavioral and other nonpharmacological therapies, 18 Food and Drug Administration-approved pharmacotherapies, and numerous off-label, over the counter and alternative treatments. Most reviews on this subject focus either on pharmacological treatments or behavioral treatments. The authors provide a combined review of available pharmacological and nonpharmacological treatments. The authors narratively reviewed each treatment from our literature search, tabled results with the highest level of available evidence on 5 major sleep outcomes and evaluated these results for clinical significance. The authors also evaluated the safety of pharmacotherapies within the context of the 2019 Beers Criteria for Potentially Inappropriate Medications in the Elderly. The authors found the most rigorous evidence supporting Cognitive Behavioral Therapy for Insomnia as a first-line treatment option, with longer lasting therapeutic effects than treatment with pharmacologic agents alone. The authors also found evidence of similar outcomes from other behavioral interventions, such as Brief Behavioral Therapy for Insomnia and relaxation training. The authors found 4 studies, 2 on relaxation training, 1 on sleep restriction, and 1 on stimulus control limited to the elderly with clinically significant results. The authors found no pharmacological studies limited to the elderly on treatments not contraindicated by Beers criteria with clinically significant results. The authors discussed the challenges of determining clinical significance in sleep studies, the lack of studies restricted to the elderly, and the role of placebo effect.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>33218915</pmid><doi>10.1016/j.jagp.2020.10.011</doi><tpages>19</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1064-7481
ispartof The American journal of geriatric psychiatry, 2021-06, Vol.29 (6), p.585-603
issn 1064-7481
1545-7214
language eng
recordid cdi_proquest_miscellaneous_2463106023
source Alma/SFX Local Collection
subjects CBT-I
Clinical significance
Cognitive behavioral therapy
Drug therapy
elderly
Evidence-based medicine
Insomnia
nonpharmacological
Older people
pharmacological treatment
Pharmacology
Placebo effect
title Evidenced-Based Review and Evaluation of Clinical Significance: Nonpharmacological and Pharmacological Treatment of Insomnia in the Elderly
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T20%3A48%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evidenced-Based%20Review%20and%20Evaluation%20of%20Clinical%20Significance:%20Nonpharmacological%20and%20Pharmacological%20Treatment%20of%20Insomnia%20in%20the%20Elderly&rft.jtitle=The%20American%20journal%20of%20geriatric%20psychiatry&rft.au=Flaxer,%20Joseph%20M.&rft.date=2021-06&rft.volume=29&rft.issue=6&rft.spage=585&rft.epage=603&rft.pages=585-603&rft.issn=1064-7481&rft.eissn=1545-7214&rft_id=info:doi/10.1016/j.jagp.2020.10.011&rft_dat=%3Cproquest_cross%3E2463106023%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2542739170&rft_id=info:pmid/33218915&rft_els_id=S1064748120305315&rfr_iscdi=true